AVD vs BIOX: stock comparison and AI forecast
American Vanguard Corp (AVD) and Bioceres Crop Solutions Corp. (BIOX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AVD American Vanguard Corp
- Market Cap
- $28M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
BIOX Bioceres Crop Solutions Corp.
- Market Cap
- $15M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AVD is 1.9 times larger than BIOX by market capitalization ($28M against $15M).
- BIOX carries 5.94 times debt per unit of equity, against 2.50 times for AVD.
- Both companies share the SEC industry classification Agricultural Chemicals.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AVD | BIOX |
|---|---|---|
| Market Cap | $28M | $15M |
| P/B Ratio | 0.15x | – |
| EPS | $-2.06 | $-3.02 |
| Book Value/Share | $6.15 | – |
| Revenue/Share | $21.22 | $4.99 |
| FCF/Share | – | $0.92 |
Profitability & Margins
| Metric | AVD | BIOX |
|---|---|---|
| ROE | -34.8% | – |
| ROA | -9.9% | – |
| ROIC | -6.7% | 10.2% |
| Gross Margin | 28.8% | 41.4% |
| Operating Margin | -5.0% | 7.4% |
| Net Margin | -10.1% | – |
| EBT Margin | -9.7% | -3.7% |
| Tax Rate | -4.0% | -8.3% |
Financial Health
| Metric | AVD | BIOX |
|---|---|---|
| Current Ratio | 2.47x | 0.90x |
| Quick Ratio | 1.40x | 0.70x |
| D/E Ratio | 2.50x | 5.94x |
| Financial Leverage | 3.50x | 7.33x |
| Interest Coverage | -0.0x | – |
| Working Capital | $249M | -$34M |
Cash Flow
| Metric | AVD | BIOX |
|---|---|---|
| Operating Cash Flow | -$42M | $69M |
| Free Cash Flow | – | $59M |
| Capital Spending | – | -$10M |
| OCF Growth YoY | – | -6.9% |
| FCF Growth YoY | – | 0.0% |
| FCF/Sales | – | 18.4% |
| CapEx/Sales | – | 3.3% |
Operational Efficiency
| Metric | AVD | BIOX |
|---|---|---|
| Asset Turnover | 0.99x | 0.57x |
| Receivables Turnover | 3.6x | – |
| Inventory Turnover | 2.5x | 2.9x |
| Fixed Assets Turnover | 12.2x | 5.2x |
| Days Sales Outstanding | 102 days | – |
| Days Inventory | 148 days | 127 days |
| Payables Period | 71 days | 175 days |
| Cash Conversion Cycle | 179 days | – |
Income Statement
| Metric | AVD | BIOX |
|---|---|---|
| Total Revenue | $626M | $319M |
| Operating Income | -$31M | $24M |
| Net Income | -$63M | – |
| R&D Expense | $29M | $16M |
| SG&A Expense | $136M | $100M |
| Cost of Goods Sold | $446M | $187M |
Dividend & Shareholder Information
| Metric | AVD | BIOX |
|---|---|---|
| Shares Outstanding | 30M | 64M |
AVD vs BIOX: stock comparison and AI forecast
Which is bigger, AVD or BIOX?
AVD is 1.9 times larger than BIOX by market capitalization ($28M against $15M).
Which one does Intratio's AI model rank higher, AVD or BIOX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.